Do stem cell-derived islets represent a commercially viable treatment for Type 1 and 2 diabetes?

Author： Wong Adrianne L   Nierras Concepcion R  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.5, Iss.6, 2010-11, pp. : 839-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cell-based therapy for the treatment of Type 1 diabetes mellitus

By Krishna K Ananda   Rao G Venkateshwara   Rao KRS Sambasiva  

Regenerative Medicine, Vol. 2, Iss. 2, 2007-03 ,pp. : 171-177

Future Medicine

Access to resources Recommend Favorite

B Cell Lymphoma-2-Modified Bone Marrow-Derived Mesenchymal Stem Cells Transplantation for the Treatment of Diabetes Mellitus-Induced Erectile Dysfunction in a Rat Model

By  

Urologia Internationalis, Vol. 98, Iss. 3, 2016-11 ,pp. : 358-366

Karger

Access to resources Recommend Favorite

Pluripotent stem cell-derived pancreatic &bgr;-cells: potential for regenerative medicine in diabetes

By Kao Der-I   Chen Shuibing  

Regenerative Medicine, Vol. 7, Iss. 4, 2012-07 ,pp. : 583-593

Future Medicine

Access to resources Recommend Favorite

Recruitment of mesenchymal stem cells by stromal cell-derived factor 1α in pulp cells from deciduous teeth

By                      

International Journal of Molecular Medicine, Vol. 36, Iss. 2, 2015-01 ,pp. : 442-448

Spandidos Publications

Access to resources Recommend Favorite

Approaches to treatment 1: How is type 2 diabetes actually treated?

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 6, 2015-11 ,pp. : 747-748

John Wiley & Sons Inc

Access to resources Recommend Favorite